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The Matsui-Kitamura (MK) stent graft (Kitagawa, Ka-nazawa, Japan) is designed to fit the curvy portions ofthe aorta because first-generation rigid skeleton–typestent grafts potentially cause kinking and endoleak as a
result of limited flexibility.1-3 The MK stent graft consists of a
custom-made, self-expandable spiral mesh of a single nitinol wire
and thin-walled polyester fabric. We report the first surgical case
of aortic arch aneurysm treated with this flexible and curved stent
graft after extra-anatomic bypass of the arch vessels4 to prepare a
landing zone for the stent graft.
Clinical Summary
A 71-year-old man with distal arch aortic aneurysm diagnosed 2
months before in another hospital was referred to our hospital
because blood-streaked sputum occurred gradually. Hypertension
and severe chronic renal failure were also present. Magnetic res-
onance imaging revealed that the enlarged saccular-type aneurysm
was pressing the lung, and this pressure was assumed to have
caused the lung injury (Figure 1, A). The size and shape of the
aorta were evaluated, and a suitable MK stent graft was ordered
immediately.
After achievement of general anesthesia, 3 Dacron conduits
with diameters of 8 mm were anastomosed to the right femoral and
bilateral subclavian arteries. During these anastomoses, another
straight conduit was anastomosed to a side of a Dacron Y graft
(proximal diameter, 16 mm) to make the outflow tract of the graft
triple. After median sternotomy, left heart bypass was established
with the right upper pulmonary vein drainage cannula and bilateral
subclavian arterial conduits. The patient was heparinized moder-
ately before these cannulations, and the activated coagulation time
was kept between 200 and 250 seconds. Left heart bypass was
switched to antegrade selective cerebral perfusion (SCP) by plac-
ing clamps on 3 arch vessels and inserting an additional arterial
cannula to the left common carotid artery (Figure 2, A). The arch
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Figure 1. Preoperative magnetic resonance imaging (A) showed an extended saccular-type aortic arch aneurysm.
Postoperative angiography (B) showed no endoleak around the MK stent graft that was inserted into the aortic
arch. Stumps of the arch vessels were closed, and blood flows were restored through extra-anatomic bypass
grafts.
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vessels were divided, and their stumps were closed with 5-0
monofilament sutures. A side-biting clamp was placed on the
ascending aorta, and the proximal end of the Y graft was anasto-
mosed to the aorta in end-to-side fashion by using 5-0 monofila-
ment sutures. Subsequently, the side-biting clamp was removed,
and the 3 outflow tracts of the Y graft were anastomosed to the 3
arch vessels, respectively, in end-to-end fashion (Figure 2, C).
After weaning from SCP, protamine was administrated once to
stop bleeding. A sufficient landing zone was prepared for the
proximal side of the stent graft by means of this extra-anatomic
bypass. After light reheparinization, a sheath (5F) was inserted into
the ascending aorta, a long guiding wire was inserted into the aorta
through the sheath, and the wire was pulled out from the right
femoral arterial conduit by using a snare catheter. The custom-
made MK stent graft with a maximum diameter of 40 mm was
delivered into the aortic arch through the right femoral arterial
conduit by a long sheath catheter (Figure 2, C and D). Intraoper-
ative angiography showed that the proximal end of the stent graft
landed in the arch, the stent graft expanded and fit well to the wall,
and no sign of the endoleak existed (Figure 1, B). Postoperative
Figure 2. The assisted circulation is shown in part A. Left heart bypass was switched to SCP by placing clamps
on 3 arch vessels. An extended aortic arch aneurysm (B) was treated with the custom-made MK stent graft (D) that
was inserted into the aortic arch after extra-anatomic arch vessel bypass construction (C).
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computed tomography showed that the size of the aneurysm was
reduced. The patient’s renal function recovered to preoperative
levels after a transient use of hemodialysis. The patient was dis-
charged from our hospital without blood-streaked sputum.
Discussion
The MK stent graft is a flexible, custom-made, curved stent graft.
It usually takes a week until we receive the stent graft after placing
an order. In this case the MK stent graft fit tightly to the 3-dimen-
sional curvy portion of the aorta and did not cause kinking or
endoleak at all. Although total replacement of the aortic arch
would be one of the best solutions for the aortic arch aneurysm,
this procedure is surgically stressful, especially for patients with
complications.5 Advantages of endovascular stent graft delivery
with extra-anatomic arch vessel bypass by SCP are relief from
cardiac arrest, relief from circulatory arrest, and relief from use of
an oxygenator. The preoperative creatinine clearance value of this
patient was 18 mL/min, and the postoperative renal function re-
covered to preoperative levels after transient use of dialysis. This
suggested that the level of surgical stress of this procedure was
acceptable for this patient. SCP alone requires lower levels of
heparinization than cardiopulmonary bypass because of the lack of
an oxygenator. It is a big advantage of this procedure to prevent
bleeding in a patient with such potential for massive lung bleeding.
To reduce the risk of brain complications, we closed the arch
vessels before the use of the side-biting clamp.
Endovascular delivery of the MK stent graft with extra-ana-
tomic arch vessel bypass by using SCP could be a useful and
minimally invasive therapeutic strategy for patients with aortic
arch aneurysms who are considered at high surgical risk.
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Does bridging to transplantation with a left ventricular assist device
adversely affect posttransplantation survival? A comparative analysis of
mechanical versus inotropic support
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Implantation of a left ventricular assist device (LVAD) as abridge to transplantation has become an acceptable interven-tion in patients with end-stage heart failure.1,2 Patientsbridged to transplantation with LVADs have demonstrated
improvements in blood pressure, hepatic function, renal function,
physical function, and quality of life.3,4 However, whether me-
chanical support adversely affects posttransplantation survival is
still controversial.5 Do patients bridged to transplantation with an
LVAD demonstrate decreased posttransplantation survival com-
pared with patients bridged with inotropic support? The aim of this
study was to answer this question.
Patients and Methods
We retrospectively reviewed our experience at Columbia Presby-
terian Medical Center with bridge-to-transplantation patients from
June 1996 through September 2002. During this time period, 266
patients in United Network for Organ Sharing status 1 were
successfully bridged to transplantation by either mechanical (n 
121, 45.7%) or inotropic (n 145, 54.5%) support. LVAD support
was provided by the HeartMate single-lead vented electric device
(Thoratec, Pleasanton, Calif). Posttransplantation survival at 1, 3,
and 5 years was evaluated in both groups.
Data were represented as frequency distributions and percent-
ages. Values of continuous variables were expressed as means 
SD. Continuous variables were compared by independent samples
t tests, whereas categorical variables were compared by 2 tests.
Kaplan-Meier analysis was used to calculate survival. Actuarial
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